James Januzzi

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Hiddo Lambers Heerspink

University of Groningen

NETHERLANDS

View details

Josef Coresh

Professor

Johns Hopkins University

UNITED STATES

View details

Mansoor Husain

CANADA

View details

Naveed Sattar

Professor of Metabolic Medicine

University of Glasgow

UNITED KINGDOM

View details

Deidra C. Crews

Johns Hopkins University School of Medicine

UNITED STATES

View details

Carolyn SP Lam

NETHERLANDS

View details

Stefan Anker

Charité

GERMANY

View details

Sanjiv Shah

Northwestern University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Januzzi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial

Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials

Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled

Race-Free Creatinine-Based Estimation of GFR and Projection of CKD to 2060 in the United States

Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study

Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled

Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause

Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

Collaborators (8)

Hiddo Lambers Heerspink

Josef Coresh

Mansoor Husain

Naveed Sattar

Deidra C. Crews

Carolyn SP Lam

Stefan Anker

Sanjiv Shah

Make your next move.